Recent advances in the treatment of breast cancer.
 Multidisciplinary efforts have defined a number of prognostic factors and newer strategies to improve the outcome of patients with breast cancer.
 Conservative surgery has led to improved functional and cosmetic results.
 The development of a number of effective adjuvant regimens has led to improved survival.
 In patients with stage I disease, several biological characteristics of tumor have been identified that are associated with increased risk of relapse.
 A multimodality approach to patients with locally advanced disease and inflammatory cancer has resulted in improved survival.
 A number of hormonal and cytotoxic drug contaminations can palliate metastatic disease, with a small fraction of patients remaining in extended remission.
 Dose-intensive programs may lead to further improvements in survival of selected patients with this disease.
